The company might not be around to worry about: Cash at end of quater $306000. Estimated operating costs for next quarter $1.05m. Staff costs alone over $500k. Maxed out it's overdraft facility already, already spent the $1400000 it raised earlier in 2018.
Still running the old line of expected revenues from china of $120m but still no evidence of it in the form of any revenue at all froma deal apparently secured in 2016?? Even the australian ops are running at a loss. Share price has plummeted below 2.5c
How is this still trading despite ASX asking the company questions back in Nov??
It will be pretty hard to sell if you hold. Thank Goodness I didn't buy 18 months ago when I first started looking at this just above 20c/share.
R
- Forums
- ASX - By Stock
- Board of directors
The company might not be around to worry about: Cash at end of...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BEE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online